Recombinant MVA virus, and the use thereof

Details Recombinant MVA virus, and the use thereof Recombinant MVA virus, and the use thereof

2007-04-03

2007-04-03

Zeman, Robert A. (Department: 1645)

Chemistry: molecular biology and microbiology

Virus or bacteriophage, except for viral vector or...

C435S005000, C424S184100, C424S199100, C424S204100, C424S205100, C424S232100

Reexamination Certificate

active

10147284

ABSTRACT:
The present invention relates to recombinant vaccinia viruses derived from the modified vaccinia virus Ankara (MVA) and containing and capable of expressing foreign genes which are inserted at the site of a naturally occurring deletion in the MVA genome, and the use of such recombinant MVA viruses for the production of polypeptides, e.g. antigens or therapeutic agents, or viral vectors for gene therapy, and the use of such recombinant MVA viruses encoding antigens as vaccines.

REFERENCES:
patent: 5185146 (1993-02-01), Altenburger
patent: 5221610 (1993-06-01), Montagnier et al.
patent: 5676950 (1997-10-01), Small, Jr. et al.
patent: 5679511 (1997-10-01), Kwon
patent: 568 392 (1975-10-01), None
patent: 324350 (1989-07-01), None
Greenspan et al. (Nature Biotechnology 7: 936-937, 1999).
Bowie et al (Science, 1990, 257:1306-1310).
Sutter, G., et al., “A Recombinant Vector Derived from the Host Range-Restricted and Highly Attenuated MVA Strain of Vaccinia Virus Stimulates Protective Immunity in Mice to Influenza Virus,”Vaccine, 12(11) :1032-1040 (1994).
Hirsch, V.M., et al., “Limited Virus Replication Following SIV Challenge of Macaques Immunized with Attenuated MVA Vaccinia Expressing SIVsmenvandgag-pol,” Vaccines 95,Cold Spring Harbor Laboratory Press, USA, pp. 195-200 (1995).
Mayr, A., et al., “Abstammung, Eigenschaften und Verwendung des Attenuierten Vaccinia-Stammes MVA,”Infection, 3:6-14 (1975), Abstract only.
Mayr, A., et al., “The Smallpox Vaccination Strain MVA: Marker, Genetic Structure, Experience Gained with the Parenteral Vaccination and Behavior in Organisms with a Debilitated Defence Mechanism,”Zbl. Bakt. Hyg., I Abt. Org. B, 167:375-390 (1978), Abstract only.
Meyer, H., et al., “Mapping of Deletions in the Genome of the Highly Attenuated Vaccinia Virus MVA and their Influence on Virulence,”J. Gen. Virol.,72:1031-1038 (1991).
Stickl, H., et al., “MVA-Stufenimpfung Gegen Pocken”Dtsch. Med. Wschr.,99:2386-2392 (1974), Abstract only.
Sutter, G. and Moss, B., “Nonreplicating Vaccinia Vector Efficiently Expresses Recombinant Genes,”Proc. Natl. Acad. Sci., USA, 89:10847-10851 (1992).
Sutter, G. and Moss, B., “Novel Vaccinia Vector Derived from the Host Range Restricted and Highly Attenuated MVA Strain of Vaccinia Virus,”Dev. Biol. Stand. Basel, Karger, 84:195-200 (1995).
Altenburger, W., et al., “Partial Deletion of the Human Host Range Gene in the Attenuated Vaccinia Virus MVA,”Arch. Virol.,105:15-27 (1989).
Hirsch, V.M., et al., “Patterns of Viral Replication Correlate with Outcome in Simian Immunodeficiency Virus (SIV) -Infected Macaques: Effect of Prior Immunization with a Trivalent SIV Vaccine in Modified Vaccinia Virus Ankara,”J. Virol.,70(6) :3741-3752 (1996).
Wyatt, et al., “Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells”,Virol.,210:202-205 (1995).
Carroll, M.W., et al., “E. coliβ-glucuronidase (GUS) as a marker for recombinant vaccinia viruses”,Biotechniques, 19:352-355 (1995).
NTIS Accession No. PB89144802; “Novel Inhibitor of HIV Infection”.
NTIS Accession No. PB88201363, “Novel Recombinant Vaccinia Virus Expression Vectors and Method of Selecting Same”.
NTIS Accession No. PB88192059, “A Synthetic Antigen Evoking Anti-HIV Response”.
Sutter, G., et al., “Non-Replicating Vaccinia Vector Efficiently Expresses Bacteriophage T7 RNA Polymerase,”FEBS Letters371:9-12 (1995).

Affiliated with

Also associated with

Rating

Recombinant MVA virus, and the use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant MVA virus, and the use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant MVA virus, and the use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3790216